166EGP
- Active ingredient
- ivabradine
- Strength
- 5 mg
- Form
- tablet
- Manufacturer
- future pharmaceutical industries (fpi) > tabuk pharmaceutical manufacturing company
- Route
- oral.solid
Uses
Used to reduce hospitalization risk in selected patients with chronic heart failure and reduced ejection fraction.
Do not use if
Contraindicated in severe bradycardia, acute decompensated heart failure, severe hepatic impairment, and certain conduction disorders.
Side effects
Bradycardia, atrial fibrillation, hypertension, and visual brightness phenomena may occur.
Warnings
Monitor heart rate and watch for atrial fibrillation. Avoid use during pregnancy.
How it works
HCN channel blocker that selectively reduces heart rate by acting on the sinoatrial node.
Storage
Store at room temperature.